Breaking News Instant updates and real-time market news.

2023-02-02 07:03:16 BMY Bristol-Myers $71.22 / -1.43 (-1.97%) 07:03 02/02/23 02/02 07:03 02/02/23 07:03	Bristol-Myers sees FY23 adjusted EPS $7.95-$8.25, consensus $8.00 FY23 total revenues are expected to increase by approximately 2% at reported rates and approximately 2% excluding foreign exchange, consensus $47.15B.	02 Feb 15 Feb 09 Mar 17 Mar 16 Jun

2023-02-02 07:03:16

BMY

Bristol-Myers

$71.22 / -1.43 (-1.97%)

07:03

02/02/23

02/02

07:03

02/02/23

07:03

Bristol-Myers sees FY23 adjusted EPS $7.95-$8.25, consensus $8.00

FY23 total revenues are expected to increase by approximately 2% at reported rates and approximately 2% excluding foreign exchange, consensus $47.15B.

02
Feb
15
Feb
09
Mar
17
Mar
16
Jun

OTHER BREAKING NEWS FROM THE FLY

Initiation	Intellia Therapeutics initiated with an Outperform at Bernstein » 05:01 03/21/23 03/21 05:01 03/21/23 05:01 NTLA Intellia Therapeutics $38.25 / -1.58 (-3.97%) Bernstein initiated… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly NTLA Intellia Therapeutics $38.25 / -1.58 (-3.97%) 03/02/23 Intellia Therapeutics announces FDA clearance of IND for NTLA-2002 01/26/23 Cathie Wood's ARK Investment bought 195K shares of Intellia Therapeutics today 01/11/23 Intellia awarded innovation passport in UK for NTLA-2002 01/05/23 Intellia Therapeutics highlights strategic priorities, milestones for 2023 NTLA Intellia Therapeutics $38.25 / -1.58 (-3.97%) 03/13/23 BMO Capital Intellia Therapeutics upgraded to Outperform from Market Perform at BMO Capital 03/10/23 Stifel Stifel says SVB fallout 'appears limited' across firm's biotech coverage 02/24/23 Chardan Intellia Therapeutics price target lowered to $111 from $129 at Chardan 02/24/23 Baird Intellia Therapeutics price target lowered to $42 from $58 at Baird NTLA Intellia Therapeutics $38.25 / -1.58 (-3.97%) 02/23/23 Intellia Therapeutics reports Q4 EPS ($1.40), consensus ($1.39) 11/03/22 Intellia Therapeutics reports Q3 EPS ($1.49), consensus ($1.28) 01 Dec NTLA Intellia Therapeutics $38.25 / -1.58 (-3.97%) 01/24/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/11/22 Sell these stocks now, proven algorithm says 09/23/22 Sell these stocks now, proven algorithm says 09/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Initiation	Ionis Pharmaceuticals initiated with an Underperform at Bernstein » 05:00 03/21/23 03/21 05:00 03/21/23 05:00 IONS Ionis Pharmaceuticals $35.57 / +0.39 (+1.11%) Bernstein analyst William… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings IONS Ionis Pharmaceuticals $35.57 / +0.39 (+1.11%) 03/07/23 Ionis Pharmaceuticals: FDA accepts NDA for eplontersen 02/01/23 Ionis Pharmaceuticals: GSK advances bepirovirsen into Phase 3 development 01/31/23 Ionis Pharmaceuticals receives FDA Fast Track designation for olezarsen 01/23/23 Ionis confirms FDA to hold advisory committee meeting on tofersen NDA IONS Ionis Pharmaceuticals $35.57 / +0.39 (+1.11%) 02/23/23 SVB Securities Ionis Pharmaceuticals price target lowered to $27 from $34 at SVB Securities 02/23/23 Barclays Ionis Pharmaceuticals price target lowered to $40 from $44 at Barclays 01/19/23 Piper Sandler Ionis Pharmaceuticals price target raised to $62 from $60 at Piper Sandler 12/21/22 Guggenheim Ionis 2023 revenue estimate raised at Guggenheim IONS Ionis Pharmaceuticals $35.57 / +0.39 (+1.11%) 02/22/23 Ionis Pharmaceuticals sees FY23 revenue $575M, consensus $672.18M 02/22/23 Ionis Pharmaceuticals reports Q4 EPS (37c), consensus (92c) 11/09/22 Ionis Pharmaceuticals backs 2022 revenue above $575M, consensus $594.45M 11/09/22 Ionis Pharmaceuticals reports Q3 EPS (33c), consensus (74c)
Initiation	Alnylam initiated with an Outperform at Bernstein » 04:59 03/21/23 03/21 04:59 03/21/23 04:59 ALNY Alnylam $187.47 / +2.01 (+1.08%) Bernstein analyst William… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events ALNY Alnylam $187.47 / +2.01 (+1.08%) 03/09/23 Alnylam and Medison Pharma expand multi-regional partnership to Eastern Europe 02/21/23 Alnylam announces FDA acceptance of patisiran sNDA 01/05/23 Alnylam names Amy Schulman board chair 12/21/22 Alnylam submits CTA application for type 2 diabetes treatment ALN-KHK ALNY Alnylam $187.47 / +2.01 (+1.08%) 02/24/23 Canaccord Alnylam price target lowered to $291 from $310 at Canaccord 02/24/23 Citi Alnylam price target lowered to $265 from $270 at Citi 02/24/23 SVB Securities SVB downgrades Moderna to Underperform as COVID boom reverses 02/21/23 EF Hutton Alnylam initiated with a Buy at EF Hutton ALNY Alnylam $187.47 / +2.01 (+1.08%) 02/23/23 Alnylam sees FY23 revenue $1.2B-$1.285B, consensus $1.48B 02/23/23 Alnylam reports Q4 EPS ($1.39), consensus ($1.90) 10/27/22 Alnylam reports Q3 EPS ($1.58), consensus ($1.77) ALNY Alnylam $187.47 / +2.01 (+1.08%) 02/24/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/21/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/12/22 Biotech Alert: Searches spiking for these stocks today 10/08/23 PDUFA Date for Patisiran (Onpattro)
Initiation	BioMarin initiated with an Underperform at Bernstein » 04:58 03/21/23 03/21 04:58 03/21/23 04:58 BMRN BioMarin $92.36 / +0.725 (+0.79%) Bernstein initiated… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events BMRN BioMarin $92.36 / +0.725 (+0.79%) 03/07/23 BioMarin: FDA accepts sNDA to expand use of VOXZOGO for injection 03/06/23 BioMarin says FDA extends review of BLA for Roctavian 01/08/23 BioMarin announces data from follow up from Phase 3 GENEr8-1 study of ROCTAVIAN 01/03/23 BioMarin's application for Voxzogo in achondroplasia validated by EMA BMRN BioMarin $92.36 / +0.725 (+0.79%) 03/09/23 Chardan Tenaya Therapeutics price target lowered to $24 from $28 at Chardan 02/28/23 Stifel BioMarin price target raised to $118 from $114 at Stifel 02/28/23 Wedbush BioMarin price target lowered to $74 from $83 at Wedbush 02/28/23 Canaccord BioMarin price target lowered to $112 from $119 at Canaccord BMRN BioMarin $92.36 / +0.725 (+0.79%) 02/27/23 BioMarin sees FY23 EPS under new method of $1.80-$2.05, consensus $1.61 02/27/23 BioMarin reports Q4 EPS (0c), consensus (7c) 02/27/23 Notable companies reporting after market close 10/26/22 BioMarin backs FY22 revenue view $2.06B-$2.16B, consensus $2.12B BMRN BioMarin $92.36 / +0.725 (+0.79%) 02/22/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/21/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/25/22 Biotech Alert: Searches spiking for these stocks today 11/23/22 What You Missed On Wall Street On Wednesday 06/30/23 PDUFA Date for Roctavian--Extended 10/21/23 PDUFA Date for VOXZOGO
Initiation	Vertex Pharmaceuticals initiated with an Outperform at Bernstein » 04:57 03/21/23 03/21 04:57 03/21/23 04:57 VRTX Vertex Pharmaceuticals $298.91 / +3.41 (+1.15%) Bernstein analyst William… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options VRTX Vertex Pharmaceuticals $298.91 / +3.41 (+1.15%) 03/09/23 Vertex says FDA clears IND for VX-264 with potential to treat type 1 diabetes 03/09/23 Vertex says FDA clears IND for VX-264 with potential to treat type 1 diabetes 03/01/23 ImmunoGen announces license agreement with Vertex Pharmaceuticals 02/09/23 Entrada Therapeutics closes agreement with Vertex VRTX Vertex Pharmaceuticals $298.91 / +3.41 (+1.15%) 03/01/23 Guggenheim Immunogen confident in early Elahere launch, says Guggenheim 02/22/23 Chardan Crispr Therapeutics price target lowered to $123 from $153 at Chardan 02/08/23 SVB Securities Vertex Pharmaceuticals price target lowered to $365 from $374 at SVB Securities 02/08/23 H.C. Wainwright Vertex Pharmaceuticals price target raised to $325 from $300 at H.C. Wainwright VRTX Vertex Pharmaceuticals $298.91 / +3.41 (+1.15%) 02/07/23 Vertex Pharmaceuticals guides FY23 revenue $9.55B-$9.70B, consensus $9.6B 02/07/23 Vertex Pharmaceuticals reports Q4 EPS $3.76, consensus $3.51 02/07/23 Notable companies reporting after market close 10/27/22 Vertex Pharmaceuticals raises 2022 revenue to $8.8B-$8.9B from $8.6B-$8.9B VRTX Vertex Pharmaceuticals $298.91 / +3.41 (+1.15%) 02/07/23 Vertex keeps cystic fibrosis drug out of developing countries, NY Times reports VRTX Vertex Pharmaceuticals $298.91 / +3.41 (+1.15%) 03/09/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/30/22 What You Missed On Wall Street This Morning 12/19/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 10/31/22 Biotech Alert: Searches spiking for these stocks today VRTX Vertex Pharmaceuticals $298.91 / +3.41 (+1.15%) 02/07/23 Vertex options imply 3.7% move in share price post-earnings 11/28/22 Early notable gainers among liquid option names on November 28th
Conference/Events	Roper Technologies to hold an investor day » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 ROP Roper Technologies $432.43 / +6.74 (+1.58%) Investor Day to be held… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events ROP Roper Technologies $432.43 / +6.74 (+1.58%) 01/04/23 PowerPlan launches Data Hub APIs 11/23/22 CFO of Roper Technologies Crisci sells $2.6M in company shares 11/15/22 Roper Technologies announces transition plan for CFO 11/10/22 Roper Technologies raises dividend 10% to 68.25c per share ROP Roper Technologies $432.43 / +6.74 (+1.58%) 03/20/23 Baird Roper Technologies assumed with a Neutral at Baird 03/20/23 Truist Roper Technologies initiated with a Buy at Truist 02/23/23 Wolfe Research Roper Technologies upgraded to Outperform from Peer Perform at Wolfe Research 10/27/22 Wells Fargo Roper Technologies price target raised to $540 from $500 at Wells Fargo ROP Roper Technologies $432.43 / +6.74 (+1.58%) 01/27/23 Roper Technologies sees Q1 adjusted EPS $3.80-$3.84, consensus $3.82 01/27/23 Roper Technologies sees FY23 adjusted EPS $15.90-$16.20, consensus $15.95 01/27/23 Roper Technologies reports Q4 adjusted EPS $3.92, consensus $3.77 10/26/22 Roper Technologies raises FY22 adj. EPS view to $14.09-$14.13 from $13.46-$13.62 ROP Roper Technologies $432.43 / +6.74 (+1.58%) 02/21/23 Fly Insider: Roper, Aflac among week's notable insider trades 08:30 Today Roper Technologies
Conference/Events	Glacier Bancorp participates in a conference call with DA Davidson » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 GBCI Glacier Bancorp $41.79 / +0.57 (+1.38%) Conference call with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Events GBCI Glacier Bancorp $41.79 / +0.57 (+1.38%) 02/21/23 Raymond James Glacier Bancorp upgraded to Outperform from Market Perform at Raymond James 02/21/23 Raymond James Glacier Bancorp upgraded to Outperform from Market Perform at Raymond James 02/01/23 Truist Glacier Bancorp price target lowered to $50 from $62 at Truist 12/09/22 Truist Glacier Bancorp price target lowered to $62 from $68 at Truist GBCI Glacier Bancorp $41.79 / +0.57 (+1.38%) 01/26/23 Glacier Bancorp reports Q4 EPS 72c, consensus 73c 10/20/22 Glacier Bancorp reports Q3 EPS 72c, consensus 73c 13:00 Today Glacier Bancorp - GBCI 04/26/23 Glacier Bancorp
Conference/Events	Brink's management to meet with Truist » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 BCO Brink's $61.30 / +0.69 (+1.14%) Meetings to be held with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events BCO Brink's $61.30 / +0.69 (+1.14%) 10/03/22 Brink's acquires NoteMachine for $179M BCO Brink's $61.30 / +0.69 (+1.14%) 08/01/22 Truist Brink's price target lowered to $78 from $96 at Truist BCO Brink's $61.30 / +0.69 (+1.14%) 02/22/23 Brink's sees FY23 adjusted EPS $6.30-$7.00, two estimates $6.53 02/22/23 Brink's reports Q4 adjusted EPS $2.10 vs. $1.68 a year ago 10/26/22 Brink's narrows FY22 adjusted EPS view to $5.75 from $5.50-$6.00 10/26/22 Brink's reports Q3 adjusted EPS $1.34 vs $1.14 last year BCO Brink's $61.30 / +0.69 (+1.14%) 03/20/23 Fly Insider: Southwest Gas, Pathward among week's notable insider trades 00:00 Today Brink's 03/22/23 Brink's 05/05/23 The Brink's Company
Conference/Events	Five Below management to meet virtually with Loop Capital » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 FIVE Five Below $199.16 / +6.09 (+3.15%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options FIVE Five Below $199.16 / +6.09 (+3.15%) 03/15/23 Five Below falls 4% to $189.99 after Q4 results, below-consensus guidance 03/15/23 Five Below sees FY23 comparable sales up 1%-4% 03/15/23 Five Below sees Q1 comparable sales up 2.5%-4% 03/13/23 Five Below promotes Kenneth Bull to COO FIVE Five Below $199.16 / +6.09 (+3.15%) 03/20/23 Citi Five Below price target raised to $225 from $220 at Citi 03/16/23 Deutsche Bank Five Below price target raised to $238 from $234 at Deutsche Bank 03/16/23 Truist Five Below price target raised to $224 from $217 at Truist 03/16/23 Loop Capital Five Below price target raised to $190 from $175 at Loop Capital FIVE Five Below $199.16 / +6.09 (+3.15%) 03/15/23 Five Below sees FY23 EPS $5.25-$5.76, consensus $5.67 03/15/23 Five Below sees Q1 EPS 59c-65c, consensus 68c 03/15/23 Five Below reports Q4 EPS $3.07, consensus $3.07 01/09/23 Five Below sees Q4 and FY22 'near high end of prior guidance ranges' FIVE Five Below $199.16 / +6.09 (+3.15%) 03/16/23 What You Missed On Wall Street On Thursday 03/16/23 What You Missed On Wall Street This Morning 03/15/23 Fly Intel: After-Hours Movers 02/18/23 Buy/Sell: Wall Street's top 10 stock calls this week 03/28/23 Northland Hosted Company Meetings at 2023 Enterprise Connect Conference 00:00 Today Five Below 04/05/23 Five Below FIVE Five Below $199.16 / +6.09 (+3.15%) 03/15/23 Five Below options imply 6.1% move in share price post-earnings 11/30/22 Five Below options imply 7.2% move in share price post-earnings
Conference/Events	Lincoln Educational management to meet with Lake Street » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 LINC Lincoln Educational $5.16 / -0.17 (-3.19%) Meeting to be held with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events LINC Lincoln Educational $5.16 / -0.17 (-3.19%) 11/30/22 Lincoln Educational reports mandatory conversion of Series A stock 11/10/22 Lincoln Educational introduces medical assistant training at East Windsor campus LINC Lincoln Educational $5.16 / -0.17 (-3.19%) 09/08/22 Rosenblatt Rosenblatt starts Lincoln Educational at Buy on 'compelling' risk/reward 09/08/22 Rosenblatt Lincoln Educational initiated with a Buy at Rosenblatt 08/08/22 Barrington Lincoln Educational price target lowered to $8.50 from $9.50 at Barrington 06/30/22 Lake Street Lincoln Educational initiated with a Buy at Lake Street LINC Lincoln Educational $5.16 / -0.17 (-3.19%) 02/27/23 Lincoln Educational sees 2023 revenue $345M-$360M, consensus $351.83M 02/27/23 Lincoln Educational reports Q4 EPS 27c, consenus 26c 11/07/22 Lincoln Educational reiterates FY22 revenue $340M-$350M, consensus $345.23M 11/07/22 Lincoln Educational reports Q3 EPS 10c, consensus 10c 00:00 Today Lincoln Educational

Conference/Events	Ryan Specialty Group management to meet with William Blair » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 RYAN Ryan Specialty Group $38.04 / -0.2 (-0.52%) Meeting to be held in New… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events RYAN Ryan Specialty Group $38.04 / -0.2 (-0.52%) 03/15/23 Ryan Specialty Group CEO buys $7.78M in common stock 01/03/23 Ryan Specialty Group completes acquisition of Griffin Underwriting Services 12/12/22 Ryan Specialty Group to acquire assets of Griffin Underwriting Services 11/17/22 Ryan Specialty Group CEO buys $6.36M in common stock RYAN Ryan Specialty Group $38.04 / -0.2 (-0.52%) 02/21/23 Autonomous Ryan Specialty Group initiated with an Underperform at Autonomous 01/19/23 BMO Capital Ryan Specialty Group initiated with an Outperform at BMO Capital 12/16/22 Wells Fargo Ryan Specialty Group upgraded to Overweight from Equal Weight at Wells Fargo 12/14/22 Citi Citi expands P&C insurance coverage with Arthur J. Gallagher top pick RYAN Ryan Specialty Group $38.04 / -0.2 (-0.52%) 02/28/23 Ryan Specialty Group sees FY23 organic revenue growth 10%-13%, consensus $2B 02/28/23 Ryan Specialty Group reports Q4 adjusted EPS 27c, consensus 26c 11/10/22 Ryan Specialty Group reports Q3 adjusted EPS 25c, consensus 26c RYAN Ryan Specialty Group $38.04 / -0.2 (-0.52%) 11/28/22 Fly Insider: Autoscope, Archer Aviation among week's notable insider trades 11/11/22 What You Missed On Wall Street On Friday 11/11/22 What You Missed On Wall Street This Morning 00:00 Today Ryan Specialty Group
Conference/Events	Northeast Bank management to meet with Piper Sandler » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 NBN Northeast Bank $37.87 / -0.07 (-0.18%) Meetings to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events NBN Northeast Bank $37.87 / -0.07 (-0.18%) 12/12/22 Northeast Bank announces commencement of at-the-market offering NBN Northeast Bank $37.87 / -0.07 (-0.18%) 12/09/22 Piper Sandler Northeast Bank price target raised to $60 from $46 at Piper Sandler NBN Northeast Bank $37.87 / -0.07 (-0.18%) 10/31/22 Northeast Bancorp reports Q1 EPS $1.12 vs $1.20 last year 00:00 Today Northeast Bank
Conference/Events	ASGN management to meet with William Blair » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 ASGN ASGN $80.79 / +0.265 (+0.33%) Meeting to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events ASGN ASGN $80.79 / +0.265 (+0.33%) 10/03/22 ASGN acquires Iron Vine Security, terms undisclosed ASGN ASGN $80.79 / +0.265 (+0.33%) 02/09/23 Baird ASGN price target lowered to $103 from $108 at Baird 08/08/22 BofA ASGN price target raised to $122 from $120 at BofA 07/29/22 BMO Capital ASGN price target raised to $105 from $94 at BMO Capital 06/14/22 Truist ASGN price target lowered to $110 from $150 at Truist ASGN ASGN $80.79 / +0.265 (+0.33%) 02/08/23 ASGN sees Q1 adjusted EPS $1.37-$1.45, consensus $1.49 02/08/23 ASGN reports Q4 adjusted EPS $1.51, consensus $1.49 10/26/22 ASGN sees Q4 adjusted EPS $1.44-$1.51, consensus $1.62 10/26/22 ASGN reports Q3 adjusted EPS $1.79, consensus $1.78 00:00 Today ASGN
Conference/Events	Perion Network management to meet virtually with Oppenheimer » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 PERI Perion Network $35.21 / -0.26 (-0.73%) Virtual Meetings to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options PERI Perion Network $35.21 / -0.26 (-0.73%) 02/08/23 Perion Network announces six-month CEO transition period PERI Perion Network $35.21 / -0.26 (-0.73%) 01/30/23 Needham Perion Network price target raised to $37 from $32 at Needham 01/20/23 Lake Street Lake Street 'comfortable' with revenue growth forecast for Perion Network PERI Perion Network $35.21 / -0.26 (-0.73%) 02/08/23 Perion Network sees FY23 revenue $720M-$740M, consensus $730.03M 02/08/23 Perion Network reports Q4 adjusted EPS 90c, consensus 59c 01/04/23 Perion Network reports preliminary FY22 revenue $636M, consensus $632.26.6M 01/04/23 Perion Network reports preliminary Q4 revenue $205M, consensus $201.6M PERI Perion Network $35.21 / -0.26 (-0.73%) 01/04/23 What You Missed On Wall Street On Wednesday 01/04/23 What You Missed On Wall Street This Morning 01/04/23 Fly Intel: Pre-market Movers 10/06/22 What You Missed On Wall Street On Thursday 00:00 Today Perion Network PERI Perion Network $35.21 / -0.26 (-0.73%) 12/09/22 Largest borrow rate increases among liquid names 12/06/22 Largest borrow rate increases among liquid names 11/25/22 Largest borrow rate increases among liquid names
Conference/Events	Acutus Medical management to meet virtually with BTIG » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 AFIB Acutus Medical / + Medical Technology and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events AFIB Acutus Medical / + 02/06/23 Acutus Medical reports results from AcQForce Flutter Study 01/09/23 Acutus Medical names Takeo Mukai as CFO 12/29/22 Acutus Medical says AcQForce Flutter abstract accepted for presentation 12/21/22 Acutus Medical achieves second milestone under agreement with Medtronic AFIB Acutus Medical / + 03/17/23 Canaccord Acutus Medical price target lowered to $1.00 from $1.91 at Canaccord 06/24/22 BTIG Acutus Medical price target lowered to $1.50 from $2.00 at BTIG 04/27/22 BTIG Acutus Medical upgraded to Buy from Neutral at BTIG AFIB Acutus Medical / + 03/16/23 Acutus Medical sees FY23 revenue $18M-$21M, consensus $20.46M 03/16/23 Acutus Medical reports Q4 EPS (63c), consensus (71c) 01/09/23 Acutus Medical sees FY22 revenue $16.1M-$16.3M, consensus $15.7M 01/09/23 Acutus Medical sees Q4 revenue $4.7M-$4.9M, consensus $4.15M 03/22/23 March Small-Cap Virtual Conference 00:00 Today Acutus Medical
Conference/Events	Northwest Pipe management to meet virtually with Northland » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 NWPX Northwest Pipe $31.59 / +0.015 (+0.05%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events NWPX Northwest Pipe $31.59 / +0.015 (+0.05%) 11/22/22 Northwest Pipe to manufacture engineered steel pressure Texas pipeline project NWPX Northwest Pipe $31.59 / +0.015 (+0.05%) 01/23/23 Northland Northwest Pipe initiated with an Outperform at Northland NWPX Northwest Pipe $31.59 / +0.015 (+0.05%) 03/15/23 Northwest Pipe reports Q4 adjusted EPS 85c vs. 67c last year 03/22/23 March Small-Cap Virtual Conference 12:15 Today Northwest Pipe - NWPX 10:00 Today Northwest Pipe
Conference/Events	Franklin BSP Realty Trust management to meet with B. Riley » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 FBRT Franklin BSP Realty Trust $11.83 / +0.245 (+2.11%) Meetings to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Events FBRT Franklin BSP Realty Trust $11.83 / +0.245 (+2.11%) 09/28/22 B. Riley Franklin BSP Realty Trust initiated with Buy, $16 target at B. Riley 09/28/22 B. Riley Franklin BSP Realty Trust initiated with a Buy at B. Riley 08/18/22 JMP Securities Franklin BSP downgraded to Market Perform from Outperform at JMP Securities 04/08/22 JonesTrading Franklin BSP Realty Trust initiated with a Buy at JonesTrading FBRT Franklin BSP Realty Trust $11.83 / +0.245 (+2.11%) 02/22/23 Franklin BSP Realty Trust reports Q4 distributable EPS 37c, consensus 36c 00:00 Today Franklin BSP Realty Trust
Conference/Events	Sonic Automotive management to meet with Stephens » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 SAH Sonic Automotive $50.82 / +1.32 (+2.67%) Analyst Imbro holds… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events SAH Sonic Automotive $50.82 / +1.32 (+2.67%) 02/28/23 Sonic Automotive promotes Angela Broadway to Chief Human Resources Officer 02/15/23 Sonic Automotive acquires Black Hills Harley-Davidson, terms not disclosed 10/28/22 Sonic Automotive identified material weakness in certain internal controls 10/27/22 Sonic Automotive raises quarterly dividend 12% to 28c per share SAH Sonic Automotive $50.82 / +1.32 (+2.67%) 02/21/23 JPMorgan Sonic Automotive downgraded to Neutral from Overweight at JPMorgan 12/27/22 Morgan Stanley Used car prices still have room to decrease 'significantly,' says Morgan Stanley 10/31/22 Benchmark Sonic Automotive price target lowered to $62 from $71 at Benchmark 10/06/22 JPMorgan Sonic Automotive upgraded to Overweight from Neutral at JPMorgan SAH Sonic Automotive $50.82 / +1.32 (+2.67%) 02/15/23 Sonic Automotive reports Q4 adjusted EPS $2.61, consensus $2.22 10/27/22 Sonic Automotive reports Q3 EPS $2.23, consensus $2.47 00:00 Today Sonic Automotive 03/22/23 Sonic Automotive
Conference/Events	Embecta management to meet with Mizuho » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 EMBC Embecta $29.67 / -0.155 (-0.52%) Meeting to be held on the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events EMBC Embecta $29.67 / -0.155 (-0.52%) 01/25/23 Embecta opens new global headquarters in Parsippany, New Jersey EMBC Embecta $29.67 / -0.155 (-0.52%) 01/06/23 Morgan Stanley Morgan Stanley cuts 'longer-term execution story' Embecta to Underweight 01/06/23 Morgan Stanley Embecta downgraded to Underweight from Equal Weight at Morgan Stanley 09/08/22 BTIG Embecta initiated with a Neutral at BTIG 08/01/22 Morgan Stanley Embecta initiated with an Equal Weight at Morgan Stanley EMBC Embecta $29.67 / -0.155 (-0.52%) 02/14/23 Embecta reports Q1 adjusted EPS 96c, consensus 51c 12/20/22 Embecta sees FY23 adjusted EPS $1.75-$2.00, consensus $3.11 12/20/22 Embecta reports Q4 EPS (30c), consensus 66c EMBC Embecta $29.67 / -0.155 (-0.52%) 12/20/22 What You Missed On Wall Street On Tuesday 12/20/22 What You Missed On Wall Street This Morning 12/20/22 Fly Intel: Pre-market Movers 00:00 Today Embecta
Conference/Events	Hannon Armstrong to hold an virtual investor day » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 HASI Hannon Armstrong $23.98 / +0.09 (+0.38%) Virtual Investor Day to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events HASI Hannon Armstrong $23.98 / +0.09 (+0.38%) 03/20/23 Hannon Armstrong invests $30M in Bioenergy Devco 02/16/23 Hannon Armstrong names Jeffrey Lipson president, CEO 02/16/23 Hannon Armstrong backs annual EPS CAGR view 10%-13% 01/04/23 Hannon Armstrong Invests in a 1.3 GW renewables portfolio operated by AES HASI Hannon Armstrong $23.98 / +0.09 (+0.38%) 02/23/23 Cowen Hannon Armstrong price target lowered to $41 from $44 at Cowen 02/17/23 JPMorgan Hannon Armstrong price target lowered to $52 from $56 at JPMorgan 01/25/23 BofA Hannon Armstrong upgraded to Neutral at BofA on balance sheet acceleration 01/24/23 BofA Hannon Armstrong upgraded to Neutral from Underperform at BofA HASI Hannon Armstrong $23.98 / +0.09 (+0.38%) 02/16/23 Hannon Armstrong reports Q4 distributable EPS 47c, consensus 49c 11/03/22 Hannon Armstrong reports Q3 distributable EPS 49c, consensus 49c HASI Hannon Armstrong $23.98 / +0.09 (+0.38%) 02/13/23 What You Missed This Week in EVs and Clean Energy 01/25/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08:30 Today Hannon Armstrong

Hot Stocks	CVR Energy to replace Atlas Air in S&P 600 at open on 3/21 » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 CVI CVR Energy $30.55 / +0.77 (+2.59%) , AAWW Atlas Air $102.49 / + (+0.00%) , APO Apollo Global $56.82 / +0.25 (+0.44%) Apollo Global Management… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options CVI AAWW APO CVI CVR Energy $30.55 / +0.77 (+2.59%) 03/16/23 KBR's K-SAAT technology selected by CVR Energy 03/15/23 CVR Energy to replace Atlas Air in S&P 600 at open on 3/21 02/14/23 Icahn boosts stake in Crown Holdings, reduces stake in Cheniere Energy 01/22/23 Fly Intel: Top five weekend stock stories AAWW Atlas Air $102.49 / + (+0.00%) 03/17/23 AAR Corp. elects Dietrich to its board of directors 03/15/23 CVR Energy to replace Atlas Air in S&P 600 at open on 3/21 03/14/23 Atlas Air expects to consummate Apollo merger on or about March 17 02/01/23 Atlas Air takes delivery of final 747 to be produced by Boeing APO Apollo Global $56.82 / +0.25 (+0.44%) 03/15/23 CVR Energy to replace Atlas Air in S&P 600 at open on 3/21 03/14/23 Atlas Air expects to consummate Apollo merger on or about March 17 03/14/23 Univar to be acquired by Apollo Global funds for $8.1B 03/14/23 Univar jumps 14% after WSJ reports Apollo to buy company for $8.1B CVI AAWW APO CVI CVR Energy $30.55 / +0.77 (+2.59%) 03/08/23 UBS UBS starts eight independent refiners with three Buys 03/08/23 UBS CVR Energy initiated with a Neutral at UBS 09/15/22 Wolfe Research Wolfe downgrades CVR Energy, says bull thesis played out 09/14/22 Wolfe Research CVR Energy downgraded to Peer Perform from Outperform at Wolfe Research AAWW Atlas Air $102.49 / + (+0.00%) 08/09/22 Loop Capital Atlas Air downgraded to Hold from Buy at Loop Capital 08/05/22 Susquehanna Atlas Air downgraded to Neutral from Positive at Susquehanna 08/03/22 Stifel Atlas Air downgraded to Hold from Buy at Stifel 08/03/22 Wolfe Research Atlas Air upgraded to Peer Perform from Underperform at Wolfe Research APO Apollo Global $56.82 / +0.25 (+0.44%) 02/10/23 Keefe Bruyette Apollo Global upgraded to Outperform from Market Perform at Keefe Bruyette 01/31/23 BMO Capital Franklin Resources price target raised to $23 from $22 at BMO Capital 01/12/23 Barclays Apollo Global price target raised to $85 from $78 at Barclays 01/02/23 Keefe Bruyette Apollo Global downgraded to Market Perform from Outperform at Keefe Bruyette CVI AAWW APO CVI CVR Energy $30.55 / +0.77 (+2.59%) 02/21/23 CVR Energy reports Q4 adjusted EPS $1.68, consensus $1.48 10/31/22 CVR Energy reports Q3 adjusted EPS $1.90, consensus $1.90 AAWW Atlas Air $102.49 / + (+0.00%) 02/23/23 Atlas Air reports Q4 EPS $5.17, consensus $5.20 11/03/22 Atlas Air reports Q3 adjusted EPS $2.69, consensus $4.26 APO Apollo Global $56.82 / +0.25 (+0.44%) 02/09/23 Apollo Global reports Q4 adjusted EPS $1.42, consensus $1.50 02/08/23 Notable companies reporting before tomorrow's open 02/08/23 Notable companies reporting before tomorrow's open 11/02/22 Apollo Global reports Q3 EPS ($1.52) vs. $1.01 last year CVI AAWW APO CVI CVR Energy $30.55 / +0.77 (+2.59%) 01/21/23 Wells Fargo, Disney among stocks watched by value investors, Barron's says AAWW Atlas Air $102.49 / + (+0.00%) 10/12/22 Wheel falls off Boeing 747 cargo plane after takeoff, Bloomberg reports APO Apollo Global $56.82 / +0.25 (+0.44%) 03/14/23 Buyout titans weighing purchases from SVB loan book, FT reports 03/14/23 Apollo Global agrees to buy Univar for $8.1B including debt, WSJ reports 03/13/23 Apollo Global looking at Silicon Valley Bank book of loans, Bloomberg reports 03/13/23 Apollo Global looking at Silicon Valley Bank assets, Bloomberg reports CVI APO CVI CVR Energy $30.55 / +0.77 (+2.59%) 03/15/23 Fly Intel: After-Hours Movers APO Apollo Global $56.82 / +0.25 (+0.44%) 03/14/23 What You Missed On Wall Street On Tuesday 03/14/23 What You Missed On Wall Street This Morning 03/14/23 Fly Intel: Pre-market Movers 03/04/23 Buy/Sell: Wall Street's top 10 stock calls this week AAWW APO AAWW Atlas Air $102.49 / + (+0.00%) 01/26/23 Unusually active option classes on open January 26th APO Apollo Global $56.82 / +0.25 (+0.44%) 01/09/23 Apollo Global put volume heavy and directionally bearish 12/28/22 Apollo Global put volume heavy and directionally bearish 12/22/22 Apollo Global put volume heavy and directionally bearish 12/07/22 Apollo Global put volume heavy and directionally bearish
Conference/Events	Avid Technology management to meet virtually with Northland » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 AVID Avid Technology $28.98 / +0.3 (+1.05%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events AVID Avid Technology $28.98 / +0.3 (+1.05%) 02/16/23 Avid Technology announces new Pro Tools Scripting SDK 11/30/22 TV MIDTVEST expands strategic relationship with Avid Technology 11/28/22 Avid Technology appoints Deb Sanders as CCO 10/13/22 Avid Technology announces amended credit facility AVID Avid Technology $28.98 / +0.3 (+1.05%) 03/06/23 Truist Avid Technology initiated with a Buy at Truist 08/03/22 B. Riley Avid Technology price target lowered to $34 from $45 at B. Riley 07/11/22 Rosenblatt Avid Technology initiated with a Neutral at Rosenblatt 07/06/22 JPMorgan Avid Technology initiated with an Overweight at JPMorgan AVID Avid Technology $28.98 / +0.3 (+1.05%) 03/01/23 Avid Technology sees FY23 EPS $1.53-$1.75, consensus $1.63 03/01/23 Avid Technology sees Q1 EPS 21c-29c, consensus 31c 03/01/23 Avid Technology reports Q4 EPS 45c, consensus 48c 11/08/22 Avid Technology sees FY22 adjusted EPS $1.40-$1.50, consensus $1.44 AVID Avid Technology $28.98 / +0.3 (+1.05%) 03/01/23 Fly Intel: After-Hours Movers 11/08/22 Fly Intel: After-Hours Movers 09:30 Today Avid Technology
Conference/Events	Brixmor management to meet with KeyBanc » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 BRX Brixmor $20.50 / +0.465 (+2.32%) Meetings to be held with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events BRX Brixmor $20.50 / +0.465 (+2.32%) 02/03/23 Brixmor chair John Schreiber to retire, Crosland named next chair BRX Brixmor $20.50 / +0.465 (+2.32%) 12/16/22 Wolfe Research Brixmor upgraded to Outperform at Wolfe Research on steady internal growth 12/15/22 Wolfe Research Brixmor upgraded to Outperform from Peer Perform at Wolfe Research 12/15/22 Piper Sandler Federal Realty downgraded to Neutral from Overweight at Piper Sandler 12/06/22 Barclays Brixmor price target raised to $28 from $26 at Barclays BRX Brixmor $20.50 / +0.465 (+2.32%) 02/13/23 Brixmor sees 2023 FFO $1.95-$2.03, consensus $2.01 02/13/23 Brixmor reports Q4 FFO 49c, consensus 49c 11/01/22 Brixmor sees FY22 NAREIT FFO $1.94-$1.97, consensus $1.96 11/01/22 Brixmor reports Q3 NAREIT FFO 49c, consensus 49c 05/11/23 2023 Real Estate Summit 05/02/23 Brixmor - BRX 00:00 Today Brixmor 03/22/23 Brixmor 04/26/23 Brixmor Property Group Inc.
Conference/Events	Consol Energy management to meet with Benchmark » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 CEIX Consol Energy $53.11 / -0.2 (-0.38%) Analyst Martin holds a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Events CEIX Consol Energy $53.11 / -0.2 (-0.38%) 03/01/23 Einhorn discusses Tenet, Consol, Teck Resources longs on CNBC 02/14/23 Greenlight buys Tenet, exits Intel in Q4 12/02/22 Consol Energy CEO sells $1.2M in common stock 11/14/22 Greenlight takes new stake in Intel, exits position in Atlas Air CEIX Consol Energy $53.11 / -0.2 (-0.38%) 01/17/23 B. Riley Consol Energy price target lowered to $84 from $85 at B. Riley 11/02/22 Benchmark Consol Energy price target raised to $80 from $72 at Benchmark 11/02/22 B. Riley Consol Energy price target raised to $85 from $80 at B. Riley 10/11/22 B. Riley Consol Energy price target raised to $80 from $79 at B. Riley 00:00 Today Consol Energy
Conference/Events	Eagle Bulk Shipping management to meet with B. Riley » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 EGLE Eagle Bulk Shipping $45.14 / -0.175 (-0.39%) Meeting to be held in New… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events EGLE Eagle Bulk Shipping $45.14 / -0.175 (-0.39%) 03/03/23 Eagle Bulk Shipping falls -15.0% 03/03/23 Eagle Bulk Shipping falls -11.7% 03/03/23 Eagle Bulk Shipping falls -11.4% 01/19/23 Eagle Bulk Shipping appoints Kate Blankenship to board EGLE Eagle Bulk Shipping $45.14 / -0.175 (-0.39%) 01/30/23 Fearnley Eagle Bulk Shipping upgraded to Buy from Hold at Fearnley 01/23/23 BTIG Eagle Bulk Shipping price target raised to $70 from $60 at BTIG 10/10/22 B. Riley Eagle Bulk Shipping price target lowered to $72 from $82 at B. Riley 09/29/22 Stifel Eagle Bulk Shipping initiated with a Buy at Stifel EGLE Eagle Bulk Shipping $45.14 / -0.175 (-0.39%) 03/02/23 Eagle Bulk Shipping reports Q4 adjusted EPS $2.76, consensus $2.99 11/03/22 Eagle Bulk Shipping reports Q3 adjusted EPS $4.58, consensus $4.70 00:00 Today Eagle Bulk Shipping

Events

Earnings calls, analyst events, roadshows and more

TME
Today at 07:00

Tencent Music - TME Conference Calls
CSIQ
Today at 08:00

Canadian Solar - CSIQ Conference Calls
HUYA
Today at 08:00

Huya - HUYA Conference Calls
ONON
Today at 08:00

On Holding - ONON Conference Calls
INKT
Today at 08:30

MiNK Therapeutics - INKT Conference Calls
LMDX
Today at 08:30

LumiraDx - LMDX Conference Calls
HASI
Today at 08:30

Hannon Armstrong Firm Sponsored Meetings

Virtual Meeting
ROP
Today at 08:30

Roper Technologies Firm Sponsored Meetings

Ritz-Carlton Hotel, New York, NY
CTRN
Today at 09:00

Citi Trends - CTRN Conference Calls
OXSQ
Today at 09:00

Oxford Square Capital - OXSQ Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	MGRX X MGRX Mangoceuticals IPO Managers: Boustead $4.00 1.25M Shares
Tues	KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs, JPMorgan, Morgan Stanley $182.50 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Bristol-Myers sees FY23 adjusted EPS $7.95-$8.25, consensus $8.00

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access